| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0006 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.092 | 0.008 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.02 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.16 | 0.04 |